Evidence map›Paper›PMID 29230546›Full record

Observational studyClinical research in cardiology : official journal of the German Cardiac Society2018

Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI Registry.

Tina Backhaus, Andreas Fach, Johannes Schmucker, Eduard Fiehn, Daniela Garstka, Janina Stehmeier, Rainer Hambrecht, Harm Wienbergen

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Clinical research in cardiology : official journal of the German Cardiac Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Applying DanGer Shock Eligibility Criteria to a Real-World Cohort of Cardiogenic Shock Patients.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2025
    Article
  6. Antiplatelet therapy in acute myocardial infarction complicated by cardiogenic shock.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Review
  7. Milrinone versus dobutamine in acute myocardial infarction-related cardiogenic shock; a propensity score matched analysis.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
  8. Article
  9. Research Priorities in Critical Care Cardiology: JACC Expert Panel.Journal of the American College of Cardiology · 2023
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The CHADiagnostics (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Article
  19. Cardiogenic shock: approaching the truth.Journal of geriatric cardiology : JGC · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tina BackhausBremer Institut für Herz- und Kreislaufforschung, Klinikum Links der Weser, Klinik für Kardiologie und Angiologie, Senator-Weßling-Str. 1, 28277, Bremen, Germany. tina.backhaus@klinikum-bremen-ldw.de.ORCID http://orcid.org/0000-0002-2185-1571
Andreas FachBremer Institut für Herz- und Kreislaufforschung, Klinikum Links der Weser, Klinik für Kardiologie und Angiologie, Senator-Weßling-Str. 1, 28277, Bremen, Germany.
Johannes SchmuckerBremer Institut für Herz- und Kreislaufforschung, Klinikum Links der Weser, Klinik für Kardiologie und Angiologie, Senator-Weßling-Str. 1, 28277, Bremen, Germany.
Eduard FiehnBremer Institut für Herz- und Kreislaufforschung, Klinikum Links der Weser, Klinik für Kardiologie und Angiologie, Senator-Weßling-Str. 1, 28277, Bremen, Germany.
Daniela GarstkaBremer Institut für Herz- und Kreislaufforschung, Klinikum Links der Weser, Klinik für Kardiologie und Angiologie, Senator-Weßling-Str. 1, 28277, Bremen, Germany.
Janina StehmeierBremer Institut für Herz- und Kreislaufforschung, Klinikum Links der Weser, Klinik für Kardiologie und Angiologie, Senator-Weßling-Str. 1, 28277, Bremen, Germany.
Rainer HambrechtBremer Institut für Herz- und Kreislaufforschung, Klinikum Links der Weser, Klinik für Kardiologie und Angiologie, Senator-Weßling-Str. 1, 28277, Bremen, Germany.
Harm WienbergenBremer Institut für Herz- und Kreislaufforschung, Klinikum Links der Weser, Klinik für Kardiologie und Angiologie, Senator-Weßling-Str. 1, 28277, Bremen, Germany.
Klinikum Links der Weser · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPatients with ST-segment elevation myocardial infarction (STEMI) and consecutive cardiogenic shock (CS) represent a challenge in clinical practice. Only few 'real-world' data on therapeutic management and outcome exist.

methodsThe present analysis focuses on changes of clinical management of STEMI-patients with CS and analyzes predictors of outcome using the Bremen-STEMI registry.

resultsOut of 7865 patients with STEMI, 981 patients (13%) presented with CS. Most CS patients (88%) underwent an early percutaneous intervention (PCI). Intraaortic balloon pumps (IABP) were less implanted since 2013 (p < 0.001), the rate of drug-eluting stents and periprocedural prasugrel or ticagrelor therapy increased over the years. Overall in-hospital mortality of patients with CS was 37%, 1 year mortality was 50%. A significantly reduced 1-year mortality (2006-2009: 55%, 2010-2013: 50%; 2014-2015: 43%, p = 0.027) was observed. In a multivariate analysis significant predictors of an increased 1-year mortality were acute renal failure (OR 3.6; 95% CI 1.9-7.0), atrial fibrillation (OR 2.8; 95% CI 1.3-6.0), three-vessel disease (OR 2.5; 95% CI 1.3-4.7), age ≥ 75 years (OR 2.4, 95% CI 1.3-4.4) and anemia (OR 1.9; 95% CI 1.1-3.3). A successful performed PCI (OR 0.5, 95% CI 0.2-0.9) was associated with a significantly reduced 1-year mortality.

conclusionmanagement of patients with CS changed with a steep decrease of IABP implantations. Mortality of patients with CS decreased over the last 10 years. Especially, performance of successful PCI was associated with a reduction of mortality, indicating the crucial role of early revascularization to improve prognosis in this high-risk cohort of STEMI-patients.

Indexed as

AdenosineAgedChi-Square DistributionComorbidityDrug-Eluting StentsFemaleGermanyHeart-Assist DevicesHospital MortalityHumansIntra-Aortic Balloon PumpingLogistic ModelsMaleMiddle AgedOdds RatioPercutaneous Coronary InterventionAdenosinePlatelet Aggregation InhibitorsPrasugrel HydrochlorideTicagrelorCardiogenic shockCounter pulsationIntraaortic balloonST-segment elevation myocardial infarction

Identifiers

PMID29230546
OpenAlexW2772167757

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.